Skip to main content

Find Clinical Trials

Home
Conditions
Skin Manifestations

Clinical trial condition

Skin Manifestations

Explore clinical trials studying Skin Manifestations. Study availability and eligibility vary by location and protocol.

1,072 public trials 157 recruiting studies

Refine in advanced search Browse all conditions

Skin Manifestations trial results

Recruiting

Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia

NCT05070845

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: East Carolina University Greenville, North Carolina, United States

Liverpool Hospital Liverpool, New South Wales, Australia

South West Radiology Liverpool, New South Wales, Australia

Slade Pharmacy Mount Kuring-Gai, New South Wales, Australia

View all 31 locations

View Trial Details

Recruiting

Tolerance and Efficacy Open-label Study With RV4421B, in Various Populations With Atopic Dermatitis for 12 Weeks

NCT07014007

Conditions: Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +20 more
Locations: Insight Research Ltd Quatre Bornes, Mauritius

View Trial Details

Recruiting

Immunological Aspect of Thrombotic Thrombocytopenic Purpura (TTP)

NCT06945861

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Cytopenia, +14 more
Locations: University Rouen Hospital, Rouen, France

View Trial Details

Recruiting

Repurposing Dupilumab for Management of Pruritic Genetic Inflammatory Skin Disorders

NCT05649098

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Epidermolysis Bullosa, +13 more
Locations: Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States

View Trial Details

Recruiting

High-Dose Dexamethasone Combined With Orelabrutinib Versus High-Dose Dexamethasone Combined With Placebo in Adult Patients With Newly Diagnosed Primary Immune Thrombocytopenia

NCT07559331

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Qilu Hospital of Shandong University Jinan, Shandong, China

View Trial Details

Recruiting

Eltrombopag Combining Rituximab Versus Eltrombopag in the Management of Primary Immune Thrombocytopenia (ITP) in Adults

NCT04518475

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Tianjin, China

View Trial Details

Recruiting

Dose Dense Rituximab for High Risk Newly Diagnosed Acute Immune Thrombocytopenic Purpura

NCT04323748

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: New York Medical College Vahalla, New York, United States

View Trial Details

Recruiting

Daratumumab in Immune-mediated Thrombotic Thrombocytopenic Purpura

NCT07513948

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Cytopenia, +15 more
Locations: Angelo Bianchi Bonomi Hemophilia and Thrombosis Center Milan, Italy

View Trial Details

Recruiting

An Open-label Study of Intravenous Immunoglobulin (5%) for the Treatment of Primary Immune Thrombocytopenia

NCT07233213

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Hacettepe University Faculty of Medicine Ankara, Altındağ, Turkey (Türkiye)

İnönü University Turgut Ozal Medical Center Training and Research Hospital Malatya, Battalgazi, Turkey (Türkiye)

İstanbul University, Istanbul Faculty of Medicine Istanbul, Fatih, Turkey (Türkiye)

Erciyes University Hematology Hospital Kayseri, Melikgazi, Turkey (Türkiye)

View Trial Details

Recruiting

Efficacy of 0.5% Topical Timolol Eye Drops in the Treatment of Post-Inflammatory Erythema Following Acne Vulgaris

NCT07474883

Conditions: Acne Vulgaris, Acneiform Eruptions, Erythema, +7 more
Locations: Ho Chi Minh City Hospital of Dermato-Venereology Ho Chi Minh City, Vietnam

View Trial Details